Drug Shortage Report for PRIVA-ROSUVASTATIN
| Report ID | 78960 |
| Drug Identification Number | 02445433 |
| Brand name | PRIVA-ROSUVASTATIN |
| Common or Proper name | ROSUVASTATIN |
| Company Name | PHARMAPAR INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ROSUVASTATIN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-03-19 |
| Actual start date | 2019-03-19 |
| Estimated end date | Unknown |
| Actual end date | 2021-09-01 |
| Shortage status | Resolved |
| Updated date | 2021-10-15 |
| Company comments | choix de l'entreprise |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1565 BOUL LIONEL-BOULET VARENNES, QUEBEC CANADA J3X 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-03-20 | English | Compare |
| v2 | 2019-03-20 | French | Compare |
| v3 | 2021-10-15 | English | Compare |
| v4 | 2021-10-15 | French | Compare |
Showing 1 to 4 of 4